Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer
<b>Background/Objectives:</b> Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1) is known as an enhancer of collagen fiber deposition and cross-linking stability. However, there is limited information on its function in tumors. In this study, we aimed to elucidate the function an...
Saved in:
| Main Authors: | Zhao Zhai, Shuo Wang, Yudong Cao, Jia Liu, Qiang Zhao, Yongpeng Ji, Xiao Yang, Xingxing Tang, Jinchao Ma, Peng Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/12/12/2653 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model
by: Qiulong Lu, et al.
Published: (2025-07-01) -
PLOD3 as a novel oncogene in prognostic and immune infiltration risk model based on multi-machine learning in cervical cancer
by: Lingling Qiu, et al.
Published: (2025-03-01) -
Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer
by: Wanchun Ye, et al.
Published: (2025-04-01) -
ITGAV as a promising diagnostic, immunological, and prognostic biomarker in pan-cancer
by: Hanyang Su, et al.
Published: (2025-08-01) -
NOX4 serves as a pan-cancer prognostic biomarker and therapeutic target in tumorigenesis
by: Jiting Sun, et al.
Published: (2025-07-01)